MIME-Version: 1.0
Content-Type: multipart/related; boundary="----=_NextPart_01C9E539.2CB92EC0"

Este documento é uma Página da Web de Arquivo Único, também conhecido como Arquivo da Web. Se você estiver lendo esta mensagem, o seu navegador ou editor não oferecem suporte a Arquivos da Web. Baixe um navegador que ofereça suporte a Arquivos da Web, como o Windows® Internet Explorer®.

------=_NextPart_01C9E539.2CB92EC0
Content-Location: file:///C:/C9064493/CalmanteseAnfetaminas.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="us-ascii"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dus-ascii">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 12">
<meta name=3DOriginator content=3D"Microsoft Word 12">
<link rel=3DFile-List href=3D"CalmanteseAnfetaminas_arquivos/filelist.xml">
<link rel=3DEdit-Time-Data href=3D"CalmanteseAnfetaminas_arquivos/editdata.=
mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Caho</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>Caho</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>2</o:TotalTime>
  <o:Created>2009-06-04T20:23:00Z</o:Created>
  <o:LastSaved>2009-06-04T20:23:00Z</o:LastSaved>
  <o:Pages>4</o:Pages>
  <o:Words>1527</o:Words>
  <o:Characters>8246</o:Characters>
  <o:Lines>68</o:Lines>
  <o:Paragraphs>19</o:Paragraphs>
  <o:CharactersWithSpaces>9754</o:CharactersWithSpaces>
  <o:Version>12.00</o:Version>
 </o:DocumentProperties>
</xml><![endif]-->
<link rel=3DthemeData href=3D"CalmanteseAnfetaminas_arquivos/themedata.thmx=
">
<link rel=3DcolorSchemeMapping
href=3D"CalmanteseAnfetaminas_arquivos/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:HyphenationZone>21</w:HyphenationZone>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>PT-BR</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:DontVertAlignCellWithSp/>
   <w:DontBreakConstrainedForcedTables/>
   <w:DontVertAlignInTxbx/>
   <w:Word11KerningPairs/>
   <w:CachedColBalance/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val=3D"Cambria Math"/>
   <m:brkBin m:val=3D"before"/>
   <m:brkBinSub m:val=3D"&#45;-"/>
   <m:smallFrac m:val=3D"off"/>
   <m:dispDef/>
   <m:lMargin m:val=3D"0"/>
   <m:rMargin m:val=3D"0"/>
   <m:defJc m:val=3D"centerGroup"/>
   <m:wrapIndent m:val=3D"1440"/>
   <m:intLim m:val=3D"subSup"/>
   <m:naryLim m:val=3D"undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState=3D"false" DefUnhideWhenUsed=3D"true"
  DefSemiHidden=3D"true" DefQFormat=3D"false" DefPriority=3D"99"
  LatentStyleCount=3D"267">
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Normal"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"heading 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"35" QFormat=3D"true" Name=3D=
"caption"/>
  <w:LsdException Locked=3D"false" Priority=3D"10" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" Name=3D"Default Paragraph=
 Font"/>
  <w:LsdException Locked=3D"false" Priority=3D"11" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtitle"/>
  <w:LsdException Locked=3D"false" Priority=3D"22" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Strong"/>
  <w:LsdException Locked=3D"false" Priority=3D"20" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"59" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Table Grid"/>
  <w:LsdException Locked=3D"false" UnhideWhenUsed=3D"false" Name=3D"Placeho=
lder Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"No Spacing"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Shading"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light List"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Dark List"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Shading"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful List"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Shading Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light List Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Grid Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 1 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 2 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 1 Accent 1"/>
  <w:LsdException Locked=3D"false" UnhideWhenUsed=3D"false" Name=3D"Revisio=
n"/>
  <w:LsdException Locked=3D"false" Priority=3D"34" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"List Paragraph"/>
  <w:LsdException Locked=3D"false" Priority=3D"29" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"30" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 2 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 1 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 2 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 3 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Dark List Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Shading Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful List Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Grid Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Shading Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light List Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Grid Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 1 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 2 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 1 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 2 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 1 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 2 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 3 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Dark List Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Shading Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful List Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Grid Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Shading Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light List Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Grid Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 1 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 2 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 1 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 2 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 1 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 2 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 3 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Dark List Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Shading Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful List Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Grid Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Shading Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light List Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Grid Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 1 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 2 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 1 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 2 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 1 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 2 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 3 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Dark List Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Shading Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful List Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Grid Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Shading Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light List Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Grid Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 1 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 2 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 1 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 2 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 1 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 2 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 3 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Dark List Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Shading Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful List Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Grid Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Shading Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light List Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Grid Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 1 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 2 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 1 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 2 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 1 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 2 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 3 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Dark List Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Shading Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful List Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Grid Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"19" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtle Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"21" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"31" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtle Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"32" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"33" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Book Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"37" Name=3D"Bibliography"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" QFormat=3D"true" Name=3D=
"TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520082689 -1073717157 41 0 66047 0;}
@font-face
	{font-family:"Arial Negrito";
	panose-1:2 11 7 4 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Texto de bal\00E3o Char";
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:"Tahoma","sans-serif";
	mso-fareast-font-family:"Times New Roman";}
p.Ttulo01, li.Ttulo01, div.Ttulo01
	{mso-style-name:"T\00EDtulo 01";
	mso-style-unhide:no;
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:24.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial Negrito","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.Marcador02, li.Marcador02, div.Marcador02
	{mso-style-name:"Marcador 02";
	mso-style-unhide:no;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:121.95pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.2pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
span.TextodebaloChar
	{mso-style-name:"Texto de bal\00E3o Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Texto de bal\00E3o";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	font-family:"Tahoma","sans-serif";
	mso-ascii-font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;
	mso-fareast-language:PT-BR;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:EN-US;}
.MsoPapDefault
	{mso-style-type:export-only;
	margin-bottom:10.0pt;
	line-height:115%;}
@page Section1
	{size:595.3pt 841.9pt;
	margin:70.85pt 3.0cm 70.85pt 3.0cm;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
 /* List Definitions */
 @list l0
	{mso-list-id:-2;
	mso-list-type:simple;
	mso-list-template-ids:-615349514;}
@list l0:level1
	{mso-level-start-at:0;
	mso-level-text:*;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l0:level1 lfo1
	{mso-level-start-at:1;
	mso-level-number-format:bullet;
	mso-level-numbering:continue;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:14.15pt;
	mso-level-legacy-space:0cm;
	margin-left:121.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Tabela normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-qformat:yes;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin-top:0cm;
	mso-para-margin-right:0cm;
	mso-para-margin-bottom:10.0pt;
	mso-para-margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-fareast-language:EN-US;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"3074"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext=3D"edit">
  <o:idmap v:ext=3D"edit" data=3D"1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=3DPT-BR style=3D'tab-interval:35.4pt'>

<div class=3DSection1>

<p class=3DTtulo01><!--[if gte vml 1]><v:shapetype id=3D"_x0000_t75" coords=
ize=3D"21600,21600"
 o:spt=3D"75" o:preferrelative=3D"t" path=3D"m@4@5l@4@11@9@11@9@5xe" filled=
=3D"f"
 stroked=3D"f">
 <v:stroke joinstyle=3D"miter"/>
 <v:formulas>
  <v:f eqn=3D"if lineDrawn pixelLineWidth 0"/>
  <v:f eqn=3D"sum @0 1 0"/>
  <v:f eqn=3D"sum 0 0 @1"/>
  <v:f eqn=3D"prod @2 1 2"/>
  <v:f eqn=3D"prod @3 21600 pixelWidth"/>
  <v:f eqn=3D"prod @3 21600 pixelHeight"/>
  <v:f eqn=3D"sum @0 0 1"/>
  <v:f eqn=3D"prod @6 1 2"/>
  <v:f eqn=3D"prod @7 21600 pixelWidth"/>
  <v:f eqn=3D"sum @8 21600 0"/>
  <v:f eqn=3D"prod @7 21600 pixelHeight"/>
  <v:f eqn=3D"sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok=3D"f" gradientshapeok=3D"t" o:connecttype=3D"rect"/>
 <o:lock v:ext=3D"edit" aspectratio=3D"t"/>
</v:shapetype><v:shape id=3D"Imagem_x0020_0" o:spid=3D"_x0000_s1026" type=
=3D"#_x0000_t75"
 alt=3D"CARA12.JPG" style=3D'position:absolute;left:0;text-align:left;
 margin-left:7.2pt;margin-top:-9.35pt;width:108.75pt;height:108.75pt;z-inde=
x:1;
 visibility:visible;mso-wrap-style:square;mso-wrap-distance-left:9pt;
 mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:text;mso-position-vertical:absolute;
 mso-position-vertical-relative:text'>
 <v:imagedata src=3D"CalmanteseAnfetaminas_arquivos/image001.jpg" o:title=
=3D"CARA12"/>
</v:shape><![endif]--><![if !vml]><span style=3D'mso-ignore:vglayout;positi=
on:
relative;z-index:1'><span style=3D'left:0px;position:absolute;left:10px;
top:-12px;width:145px;height:145px'><img width=3D145 height=3D145
src=3D"CalmanteseAnfetaminas_arquivos/image002.jpg" alt=3DCARA12.JPG v:shap=
es=3D"Imagem_x0020_0"></span></span><![endif]>Calmantes</p>

<p class=3DTtulo01>e</p>

<p class=3DTtulo01>Anfetaminas</p>

<p class=3DTtulo01><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal><span style=3D'mso-tab-count:3'>&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Os
calmantes (chamados no jarg&atilde;o t&eacute;cnico de <i style=3D'mso-bidi=
-font-style:
normal'>ansiol&iacute;ticos</i>, por aliviarem a ansiedade e a tens&atilde;=
o) e
as anfetaminas (droga com diversos prop&oacute;sitos m&eacute;dicos, sendo =
que
o mais conhecido &eacute; como rem&eacute;dio para emagrecer) est&atilde;o
entre as drogas legais mais preocupantes da atualidade no mundo inteiro. Seu
uso s&oacute; deveria ocorrer com recomenda&ccedil;&atilde;o m&eacute;dica,
pois a automedica&ccedil;&atilde;o ou a utiliza&ccedil;&atilde;o indevida p=
odem
produzir depend&ecirc;ncia. Entre os jovens, estas drogas s&atilde;o conhec=
idas
por <i style=3D'mso-bidi-font-style:normal'>bolinhas</i>.</p>

<p class=3DMsoNormal><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal><span style=3D'mso-tab-count:3'>&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Os
<b style=3D'mso-bidi-font-weight:normal'>calmantes</b> surgiram na d&eacute=
;cada
de 50 e 60. O primeiro deles, o meprobamato, foi logo abandonado, sendo que
hoje em dia s&atilde;o muito utilizados os benzodiazep&iacute;nicos (Diazep=
am,
Valium, Lorax, Lexotan, entre outros) e os barbit&uacute;ricos (o fenorbita=
l,
por exemplo). Segundo dados da Associa&ccedil;&atilde;o Brasileira da Ind&u=
acute;stria
Farmac&ecirc;utica, dos 35 milh&otilde;es de comprimidos de calmantes
comercializados no Brasil durante 1994, 75% foram consumidos por mulheres. =
Vale
aqui destacar mais uma vez Carlini e Masur, que em <i style=3D'mso-bidi-fon=
t-style:
normal'>Drogas - Subs&iacute;dios para uma discuss&atilde;o</i>, teorizam
brilhantemente sobre o consumo crescente destas drogas entre a
popula&ccedil;&atilde;o:</p>

<p class=3DMsoNormal><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span
style=3D'mso-tab-count:3'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp; </span>&#8220;Desde
a Antiguidade o homem tem procurado drogas que possam exercer esses efeitos
(calmantes), na tentativa de fugir dos problemas ou ignor&aacute;-los, em l=
ugar
de enfrent&aacute;-los ou resolv&ecirc;-los. O &aacute;lcool, v&aacute;rias
plantas e at&eacute; mesmo a maconha foram utilizados no passado, numa
tentativa de se produzir esse estado de
&#8216;tranq&uuml;iliza&ccedil;&atilde;o&#8217;. Entretanto, s&oacute;
modernamente, nos &uacute;ltimos trinta anos, foram descobertas potentes dr=
ogas
sint&eacute;ticas que possuem a propriedade quase espec&iacute;fica de prod=
uzir
esse efeito. E, como se pode deduzir, s&atilde;o drogas de muita
procura.&#8221;<o:p></o:p></i></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><o:p>&nbsp;</o=
:p></i></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span
style=3D'mso-tab-count:3'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp; </span>&#8220;Resulta
da&iacute; que tem havido um uso excessivo delas, levando a problemas
m&eacute;dicos e sociais. Conforme ser&aacute; visto adiante, parte desses
problemas &eacute; resultante da propaganda excessiva dos laborat&oacute;ri=
os
farmac&ecirc;uticos, que, na &acirc;nsia de vender mais, tentam convencer os
m&eacute;dicos e a popula&ccedil;&atilde;o que mesmo estados de discreta
ansiedade, absolutamente normais, gerados por preocupa&ccedil;&otilde;es da
vida cotidiana, precisam ser tratados.&#8221;</i></p>

<p class=3DMsoNormal><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal><span style=3D'mso-tab-count:3'>&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Al&eacute;m
dos efeitos j&aacute; mencionados, proporcionam aumento do sono, sendo
normalmente receitados em casos extremos de ansiedade, ins&ocirc;nia, como
relaxantes musculares ou anticonvulsivantes. Sua utiliza&ccedil;&atilde;o p=
or
mais de algumas semanas pode causar depend&ecirc;ncia tanto f&iacute;sica
quanto ps&iacute;quica, sendo que a toler&acirc;ncia ao medicamento
tamb&eacute;m se desenvolve. Os efeitos colaterais apresentados pelo
usu&aacute;rio s&atilde;o dificuldade na coordena&ccedil;&atilde;o motora e
lentid&atilde;o dos movimentos, aumentando consideravelmente o risco de
acidentes. O aumento do apetite, sonol&ecirc;ncia excessiva e
diminui&ccedil;&atilde;o da mem&oacute;ria e do desejo sexual s&atilde;o ou=
tras
conseq&uuml;&ecirc;ncias indesejadas. Inconsci&ecirc;ncia e at&eacute; a mo=
rte
podem resultar de doses muito elevadas, ou ainda da mistura com bebidas
alco&oacute;licas que potencializam seus efeitos. A s&iacute;ndrome de
abstin&ecirc;ncia pode trazer ansiedade, ins&ocirc;nia, agita&ccedil;&atild=
e;o,
zumbidos, tremores, tonturas, dores de cabe&ccedil;a, irritabilidade,
c&atilde;ibras, desconforto abdominal, v&ocirc;mitos, n&aacute;useas e
diarr&eacute;ias. Outro sintoma que pode acontecer &eacute; a convuls&atild=
e;o.</p>

<p class=3DMsoNormal><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal><span style=3D'mso-tab-count:3'>&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Sob
nenhum aspecto os calmantes devem ser utilizados durante a gravidez. Proble=
mas
extremamente graves como malforma&ccedil;&otilde;es, depress&atilde;o do
sistema nervoso central, sonol&ecirc;ncia, falta de apetite e flacidez da
musculatura podem acontecer com o beb&ecirc;. A crian&ccedil;a tamb&eacute;m
corre o risco de apresentar depend&ecirc;ncia ao medicamento utilizado pela
m&atilde;e.</p>

<p class=3DMsoNormal><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal><span style=3D'mso-tab-count:3'>&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>O
dr. M&aacute;rio Tannhauser, m&eacute;dico coordenador do Servi&ccedil;o de
Informa&ccedil;&otilde;es sobre Subst&acirc;ncias Psicoativas (SISP) da
Funda&ccedil;&atilde;o Faculdade Federal de Ci&ecirc;ncias M&eacute;dicas de
Porto Alegre, em <i style=3D'mso-bidi-font-style:normal'>Conversando sobre =
drogas</i>,
livro que conta ainda com a autoria das dras. Sem&iacute;ramis Tannhauser, e
Helena Maria T. Barros, m&eacute;dicas, e da farmac&ecirc;utica Cl&aacute;u=
dia
Ramos Rhoden; assim se pronunciam sobre os <b style=3D'mso-bidi-font-weight=
:normal'>cuidados
necess&aacute;rios no uso de calmantes e hipn&oacute;ticos</b>:</p>

<p class=3DMsoNormal><o:p>&nbsp;</o:p></p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Estas drogas podem produzir depend&ecirc;nci=
a,
se usadas em grande quantidade e por muito tempo. Por isto, s&oacute; podem=
 ser
vendidas quando se apresenta uma receita m&eacute;dica (tipo azul).</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>N&atilde;o use os rem&eacute;dios indicados =
para
os vizinhos, parentes ou amigos.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>N&atilde;o d&ecirc; o rem&eacute;dio que foi
receitado para voc&ecirc; aos seus vizinhos, parentes ou amigos.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Siga corretamente as instru&ccedil;&otilde;e=
s do
seu m&eacute;dico.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Caso voc&ecirc; n&atilde;o tenha compreendido
bem as instru&ccedil;&otilde;es do m&eacute;dico pergunte tantas vezes quan=
tas
forem necess&aacute;rias para que voc&ecirc; possa usar o rem&eacute;dio
corretamente.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>N&atilde;o use rem&eacute;dios vencidos.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>N&atilde;o acumule muita quantidade de
rem&eacute;dios em casa.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>N&atilde;o troque as embalagens dos
medicamentos.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Mantenha-os longe do alcance das crian&ccedi=
l;as
ou de pessoas com doen&ccedil;as psiqui&aacute;tricas.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Se o rem&eacute;dio for tomado em dose alta =
por
acidente, ou por algu&eacute;m que n&atilde;o deveria tom&aacute;-lo, dirij=
a-se
imediatamente ao servi&ccedil;o de urg&ecirc;ncia e leve o nome ou a embala=
gem
do rem&eacute;dio.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Alguns sinais de intoxica&ccedil;&atilde;o p=
odem
ocorrer, principalmente em idosos, mesmo quando for usada a dose prescrita =
pelo
m&eacute;dico. Comunique-o imediatamente.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>S&atilde;o sinais comuns de
intoxica&ccedil;&atilde;o aguda com os calmantes e rem&eacute;dios para dor=
mir:
sonol&ecirc;ncia durante o dia, dificuldade de concentra&ccedil;&atilde;o,
esquecimento e aumento do apetite. Raramente a intoxica&ccedil;&atilde;o se
manifesta com agita&ccedil;&atilde;o.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>N&atilde;o use estes medicamentos se voc&eci=
rc;
vai dirigir autom&oacute;vel, &ocirc;nibus, motocicleta, trator ou se vai
operar m&aacute;quinas autom&aacute;ticas. Informe-se com seu m&eacute;dico=
 de
como agir em rela&ccedil;&atilde;o &agrave; receita que ele lhe deu.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>N&atilde;o tome bebidas alco&oacute;licas
enquanto estiver fazendo uso destes medicamentos.</p>

<p class=3DMsoNormal><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal><span style=3D'mso-tab-count:3'>&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>A
primeira <b style=3D'mso-bidi-font-weight:normal'>anfetamina</b> a ser
sintetizada foi a d-anfetamina (dextroanfetamina) em 1928, entrando no merc=
ado
em 1932. Depois disto, v&aacute;rias outras foram fabricadas em
laborat&oacute;rios, tais como a dietilpropiona (utilizadas por medicamentos
como o Dualid, Hipofagin, Inibex, etc.), a metanfetamina (Pervitin, j&aacut=
e;
retirado do mercado brasileiro), o preludin, o mazindol, etc. As anfetaminas
foram muito utilizadas durante a II Guerra Mundial, com o objetivo de fazer=
 com
que os soldados resistissem &agrave; fadiga do combate.</p>

<p class=3DMsoNormal><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal><span style=3D'mso-tab-count:3'>&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Sua
utiliza&ccedil;&atilde;o como moderador do apetite vem sendo cada vez menos
aceita entre os m&eacute;dicos modernos. A este respeito, o psiquiatra
&Acirc;ngelo Campana, presidente da Associa&ccedil;&atilde;o Brasileira de
Estudos do &Aacute;lcool e outras Drogas (ABEAD), revela: &#8220;Sabe-se qu=
e a
modera&ccedil;&atilde;o do apetite e a obesidade t&ecirc;m mais a ver com d=
ieta
e dist&uacute;rbios de comportamento. Mesmo que estes rem&eacute;dios tirem=
 o
apetite por algum tempo, a fome volta em seguida, com mais for&ccedil;a&#82=
21;.
Ressalta ainda que a maioria dos especialistas em regimes alimentares n&ati=
lde;o
recomendam estes medicamentos para seus pacientes. &#8220;Hoje s&oacute;
&eacute; usada por curiosos e m&eacute;dicos sem conhecimento da &aacute;re=
a,
que esperam resultados apenas a curto prazo&#8221;.</p>

<p class=3DMsoNormal><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal><span style=3D'mso-tab-count:3'>&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Outra
utiliza&ccedil;&atilde;o desta droga reside no controle de doen&ccedil;as
comportamentais de crian&ccedil;as, como a hiperatividade. Mas esta
medica&ccedil;&atilde;o precoce vem sendo analisada com cuidado por
v&aacute;rios profissionais da &aacute;rea por conter excessos. O chefe do
servi&ccedil;o de psiquiatria infantil da Escola de Medicina da Universidade
Federal de S&atilde;o Paulo, Raul Gorayeb, assim pronuncia-se a este respei=
to:
&#8220;Essa tend&ecirc;ncia &agrave; medicamenta&ccedil;&atilde;o tem causas
ideol&oacute;gicas e interesseiras. &Eacute; fruto da
hipervaloriza&ccedil;&atilde;o dos aspectos biol&oacute;gicos sobre os
psicol&oacute;gicos e sociais e de um comodismo em buscar
solu&ccedil;&otilde;es r&aacute;pidas. A parte interesseira &eacute; o
marketing agressivo da ind&uacute;stria farmac&ecirc;utica&#8221;.</p>

<p class=3DMsoNormal><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal><span style=3D'mso-tab-count:3'>&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Como
drogas de abuso, destaca-se seu uso por esportistas para melhorar seu
desempenho, motoristas que querem dirigir a noite toda e estudantes que des=
ejam
passar v&aacute;rias horas estudando.</p>

<p class=3DMsoNormal><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal><span style=3D'mso-tab-count:3'>&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Os
efeitos das anfetaminas s&atilde;o falta de apetite, ins&ocirc;nia e
hiperexcitabilidade. Por n&atilde;o dormir, o usu&aacute;rio fica em um est=
ado
de excita&ccedil;&atilde;o constante, tornando-se loquaz, inquieto e
extrovertido. Doses excessivas, al&eacute;m de acentuar estes efeitos, podem
produzir tend&ecirc;ncias agressivas e psicose aguda, febre alta e
convuls&otilde;es. Estados de paran&oacute;ia com del&iacute;rios
persecut&oacute;rios (o usu&aacute;rio sente-se perseguido por outras pesso=
as)
tamb&eacute;m podem surgir. Os j&aacute; citados Carlini e Masur, em <i
style=3D'mso-bidi-font-style:normal'>Drogas: subs&iacute;dios para uma
discuss&atilde;o</i>, relatam ainda que <i style=3D'mso-bidi-font-style:nor=
mal'>&#8220;o
quadro da intoxica&ccedil;&atilde;o aguda por anfetaminas &eacute; muito
semelhante ao de um acesso de esquizofrenia paran&oacute;ide (uma doen&cced=
il;a
mental), e o m&eacute;dico &agrave;s vezes tem dificuldade para fazer o
diagn&oacute;stico diferencial&#8221;</i>.</p>

<p class=3DMsoNormal><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal><span style=3D'mso-tab-count:3'>&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Al&eacute;m
da incapacidade do usu&aacute;rio de anfetaminas, quando sob a&ccedil;&atil=
de;o
da droga, para avaliar suas condi&ccedil;&otilde;es f&iacute;sica e
psicol&oacute;gica, estas drogas ainda causam problemas card&iacute;acos
(arritmia), irritabilidade, perda de peso, ansiedade, tens&atilde;o, tremor=
es,
vertigens, irrita&ccedil;&otilde;es na pele, midr&iacute;ase (dilata&ccedil=
;&atilde;o
das pupilas) e hipertens&atilde;o arterial.</p>

<p class=3DMsoNormal><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal><span style=3D'mso-tab-count:3'>&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Ainda
n&atilde;o est&aacute; comprovado que as anfetaminas provoquem
depend&ecirc;ncia f&iacute;sica. Mas, al&eacute;m de desenvolver
toler&acirc;ncia, sabe-se que a depend&ecirc;ncia ps&iacute;quica desta dro=
ga
&eacute; muito forte. Depress&atilde;o com alto potencial suicida, fadiga e
sonol&ecirc;ncia podem surgir quando o usu&aacute;rio regular suspende o us=
o da
droga.</p>

<p class=3DMsoNormal><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal><span style=3D'mso-tab-count:3'>&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Finalizando
este cap&iacute;tulo, o dr. Jos&eacute; Elias Murad, em <i style=3D'mso-bid=
i-font-style:
normal'>Informa&ccedil;&otilde;es sobre drogas</i>, oferece-nos as seguintes
dicas para uma vida mais saud&aacute;vel:</p>

<p class=3DMsoNormal><o:p>&nbsp;</o:p></p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Procure n&atilde;o superdimensionar os
contratempos corriqueiros do dia-a-dia.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Cuide de sua alimenta&ccedil;&atilde;o,
incluindo frutas, verduras e muita &aacute;gua.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Comer equilibradamente. Se poss&iacute;vel,
moderadamente.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Comer em hor&aacute;rios regulares. Por exem=
plo,
7, 13 e 19 horas.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Evite enlatados e refrigerantes.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Abstenha-se de fumar.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Beber pouco, ou mesmo n&atilde;o faz&ecirc;-=
lo.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pratique esportes. Tenha alguma atividade
f&iacute;sica regular. Escolha aquele adequado ao seu tipo f&iacute;sico e =
de
sua prefer&ecirc;ncia.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Caso voc&ecirc; tenha algum problema de
sa&uacute;de, consulte seu m&eacute;dico sobre o esporte mais indicado em s=
eu
caso. Para aqueles que t&ecirc;m problemas card&iacute;acos, os
exerc&iacute;cios f&iacute;sicos devem ter acompanhamento m&eacute;dico.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Per&iacute;odo de sono noturno de 7 a 8 horas
por dia.</p>

<p class=3DMarcador02 style=3D'mso-list:l0 level1 lfo1'><![if !supportLists=
]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'>&middot;<span style=3D'font:7.0pt "=
Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Jamais tome rem&eacute;dios sem
indica&ccedil;&atilde;o m&eacute;dica.</p>

</div>

</body>

</html>

------=_NextPart_01C9E539.2CB92EC0
Content-Location: file:///C:/C9064493/CalmanteseAnfetaminas_arquivos/themedata.thmx
Content-Transfer-Encoding: base64
Content-Type: application/vnd.ms-officetheme
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------=_NextPart_01C9E539.2CB92EC0
Content-Location: file:///C:/C9064493/CalmanteseAnfetaminas_arquivos/colorschememapping.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"yes"?>
<a:clrMap xmlns:a=3D"http://schemas.openxmlformats.org/drawingml/2006/main"=
 bg1=3D"lt1" tx1=3D"dk1" bg2=3D"lt2" tx2=3D"dk2" accent1=3D"accent1" accent=
2=3D"accent2" accent3=3D"accent3" accent4=3D"accent4" accent5=3D"accent5" a=
ccent6=3D"accent6" hlink=3D"hlink" folHlink=3D"folHlink"/>
------=_NextPart_01C9E539.2CB92EC0
Content-Location: file:///C:/C9064493/CalmanteseAnfetaminas_arquivos/image001.jpg
Content-Transfer-Encoding: base64
Content-Type: image/jpeg
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------=_NextPart_01C9E539.2CB92EC0
Content-Location: file:///C:/C9064493/CalmanteseAnfetaminas_arquivos/image002.jpg
Content-Transfer-Encoding: base64
Content-Type: image/jpeg

/9j/4AAQSkZJRgABAQEAYABgAAD/2wBDAAoHBwgHBgoICAgLCgoLDhgQDg0NDh0VFhEYIx8lJCIf
IiEmKzcvJik0KSEiMEExNDk7Pj4+JS5ESUM8SDc9Pjv/2wBDAQoLCw4NDhwQEBw7KCIoOzs7Ozs7
Ozs7Ozs7Ozs7Ozs7Ozs7Ozs7Ozs7Ozs7Ozs7Ozs7Ozs7Ozs7Ozs7Ozs7Ozv/wAARCACRAJEDASIA
AhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQA
AAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3
ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWm
p6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEA
AwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSEx
BhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElK
U1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3
uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD2aiii
gAoopKAFpCwUZJxVG81SG2BAYFq5y+8Qu5KoxP0oA6ebUIIjgtk1Sl16JPu4rjZb6eUnLkVAWZur
E0Ade3iYL/dNIviZWPOB+NchRQB3MXiCF+uPzq7FqVvLwGwa86DMOhNTR3k8XR8/WgD0lXVhlTmn
Vw9l4gkhIDkgV0llrMVwACwzQBqUUisGGQciloAKKKKACiiigAoopCcdaAEZgq5JwKxNV1pYQyI1
M1nVQisinAHp3rkp52ncsx49KAJLq9kuXJJOD+tVqKKACiiigAooooAKKKKACpYLmS3YMh/CoNI8
7Xr+4tNOhVzayeXO0kqpsPc7eWI98VsjwlraxyPJ9iZlXKJFK2WPpkqAKANXR9b34Vzz3FdIjq6h
lOQa8vSZ4L+a2I2z223zArBl5z0IPPQ11uiawXUIxyfQ0AdLRSAhgCOhpaACiiigArP1S8FvAQD8
xFXmYKpJ7CuN8QX5kkZVPtQBjX+oJLORJMigdmYCqv2q3/57xf8AfYrkPFfiPVvDusrJpkqIJIx5
gkgSVT0x94HFNsfil4gvZxGNO0ZV7t9hzj/x6gDsftUG7b5q5/T86PtVv/z3i/77FNt/HuvpbCKb
7BJxjC2xVcemN1M/4TG9/wCgfpf/AICj/GgCdJopDhJUY+isDT6zbXULjUNT8y4ZMiM4CRqgHTsA
K0qACiiigAooqjea1p1jKsM1ypnc4WGP5nJzjoOnPrigDd8P634PWxGl6vdad9tF5KPKuFG4FpG2
8kehH511N5o/hrT7OW8u9NsIYIVLySNAuFA7niuV0/wXqGranZXWrxQW1jZTCc2pk8yWWQAFQ+Pl
AGc4yc4HrXcarYJqmk3dhJt23MLR5YZAyMA49utAHml5rOl6r4quRos8E9jHZQgNAMKrhpMr+RB/
GrVtObeUODis+4XWdDXy9d0i4RIxhr61XzoGxj5jt+Zc+4qW2u7a9hE1rPHPGRndGwNAHoei3wuY
AhPI6Vq1wuhXrQzqM9DXcIwdAw6GgB1FFFAFPUpvJtGOe1cBeyGS5YntXZeIJdtvsz1FcOxLOSe5
oAi03T7e/hF5fQtdPPKY7a3Y4TA/ibHXn+Rrp4/B/hxY1WXQtMkcD5mNonJ/KsbwmV86BJgP3bSR
xEd2Bzk/99V2dAFCPQdHiQJHpVmijoBCoFJLoGkTJsfTbfGc/Km0/mK0KKAOO13w/FpCJfaaGSHz
As8RbIwTgEZ56nGKp10Pi5n/ALHjjVsCW5jVuO2Sf6CueoAKKKKAMbxdNLb+Fr6WGRo5Aq4ZDgjL
AHmu58Nf8Iho2rReGtOtYotTFuty5MZLN8o5Lnq2GJ/OuK8TRrNoUsUgykksKMM9QZVBr1eHQtLg
1T+1I7KJb0xCI3GPnKDAAz+AoAupFHGzsiKpkbc5AxuOAMn1OAB+FPoooASvNPiVo9lp1/omp6fZ
pa3NxqCQ3E0C7PMQg8Njg9B1r0yuL+JrqdG05Aw3DVbYlc843GgDGtpPLnU+9d9pM3m2g9hXnnTm
uz8NzloQpPagDeooooA5zxO+FOOwrkRXXeJkyjfSuOllSCF5pW2pGpZjjOAKAL2h/aMWyhlQXF3I
2R1IBAwfyPFdlXnuha9ol7pUds+sQWt5auzrIZAQysc9q3rTxroSKUu/EWlyY+7Ik2C31GKAOkor
mpviJ4RglWI65A7N/wA8wzAfjjFKvxC8LOwVdVQknAAU80AWvFUe7SEkLACK4jc5784/rXOU/wAV
eOdEl0xrS3uVd2Id952bQpDdDyScVS8P6nb+IrJ723SWOFH2fvAASQAT0J9RQBaorQuNIlSZIrZh
cuyhtsfOM+9WINAYuI7mQxyHjB4C/U0AcT41uBbeFrltzK7MioV7NuBB/SuA/wCE68W/9DJqf/gU
/wDjXoPxNsJLXw+8CnzQ1wgQqPvdR09a8knt5raZobiF4ZUJDJIpVgfQg0AbX/CdeLf+hk1P/wAC
n/xo/wCE68W/9DJqf/gU/wDjWFRQBsz+MvE91C0M/iDUpI3GGVrlyD+tXfDN47NcXV1LJKUntSzM
xZsCX3rma6fwnBHNpOus4yYYreROejfaI1/kxoA9TIwSK6Xwy5JUe1c2/wB9vrXR+Gxgr7/40Add
RRRQBheI490JI/u1R8JafazxT3E0SySJIFUMM7eOv6/pW7qsPm2h46VxlhZyS65FBHO0DOT+8Q4I
GMnH5UAQ+M/D/hqPVYENjp4nljLmDy1DAA/ewO2Tj61hf8I3of8A0CLT/v0K9IuItF8O29xNLGry
XeSwfDSTkDpk9R9eBmuEguZbvzJpLA2ILnZCZlkIX6igCTS/AGm6sryQ6TYpGh2l3j6n0FT3vwyt
bS2edNJ0+42DOyNDuI9uK0tD8Ry6VZtaz2yzKHZkaNtpwTnBBp19441MmSOy0iHaRhJJLvBHvtC/
1oA4c6RoueNFsx9Y629KW10+18qzto4YWbcUjGPm7/yrOvdM8TWojlfTLZY5huVpbo5b1zhetUbX
SfGktzLdfa7W3s0ADrGhlVMn3HX3zQB2vhzxHcWWoXMeoafHFauo8ueKbexI7FcAgHP6VPqnis3F
2Vh0mWSFOFm85FL+vynpWGzrFHvldVAHLMcCqs2saZbxmSXULdUHU+YD/KgDnfFl94guJ1v9Ta2t
dLju4fLt0beygNndkDrxz+leo6jqWg+I/Eg8PCwsdSkhUNfNdJjyozyoUkfM24rwPWuGkvdA8QxN
pxvLe6WQZMavhuO49/pTLTVNS0+dI9Y8Lrqa286SQXthII55THwnmkcvwe+OR3oA669+DHgy6YGK
0uLTAxiG4bB9/mzWN/woHRP+gxf/APfKf4V0EPxNtmiUzeHNcjkI+ZVt0YA/XcM1O/xO8OrGWVdR
kkA4iWwl3E+nKgZ/HFAHMf8ACgdE/wCgxf8A/fKf4U7xD8PdE8G+DNUutMa5aWYW8UhmkDAjz4z0
AHcVqX3xRnj3Cw8JatP8nymYLH83oQCeOnNcB4j8TeNvEeoJLPoLrZRFWjsSGaMOP4mxjcc+vHTi
gDrn5c/Wut8NxcKx7V51od54gvpoV1DSYLVDy7mb5j9E5wfqa9V0ODy7YN7YoA06KKKAGyoJI2Q9
xXC67Y7JQxX7jhwemCDkH8CM13tY+uWAnhLqOT1+tAHn2qWVrrc6T6rAt7Ki7VabJKjrgVLHGkUa
xxoERAFVVGAB6VNPEYZSpHeo6ACr8t9ZzW1hp1jps8l8ZVBmwEjUnqxY/eHbH8qoUqO0bq6MVZTk
MDgg0AbfiXVNSYw6fcLbQhV33G07y/8Ad2n+AZB681R/4SDUbLQpLCxsrZ2lVhHNO5VQT6gKd35i
q9vqENlq0WpX1vNdhnAmKJ5jnjAYjqQv5101r468KXqlUvVQR8BZ7aSL8tyj9KAOS0ya2sdUS91O
xe7YQBYmgTzFgfJLEKT3+UBuvHatfUPEGkajpt1ZTafqBjuIWjbFqO4x610jWGgakq7FtmLg7TEw
Vj69K4KM3Nx4nuNHtrR5IY5Ckd5vAjfjp7kcg49KAPJB4O8RqQRpkoI5BDL/AI16XoJ1g6cv9tCE
T8BRH94Lj+Ltn6V1sOgm21i3tdSkRIpeVYNgSEfw/XmqWtRWVtrM9pZTK/lbfMjBz5RIztP4c0AU
qXcfU1oazaaZp0NisWpwSXFyDtj3gmbHJZR6Cs6gAoop0cZlkCKOTQBf0e1M9wGxwK7y3i8mBU9B
zWPoOnCFA7L0/nW7QAUUUUAFNdQ6lWGQadRQByeu6QVJdRx2Nc0ylThhgivTZoUmjKOMg1y2r6GV
JZB16GgDmqKfLE8L7XGDTKACl3N/eP50lFACYGc459afHI8UiyRuyOpyrKcEU2igC7pdxZ20t3da
jHNqF1LEI4pLh95UDJ25P3Rkg8VnwmUwqZ1jSU8uIySoPsTyfrT6KAII7G0il86O1hSXn51jAbnr
zU9FOjjeRsIM0AIql2CqMk10eiaQWIdhn1pukaIzsHYV1cECQRhVFADo41jQKowBT6KKACiiigAo
oooAKa6K6lWGQadRQBiahoUcwJQZ/pXN3eizQMdgz7V31MkgjlHzKDQB5m8TxnDqR+FNrvbjRYZc
4XrVCTw2h6KoH0oA5GiukbwyecKAKE8Nc8qT+NAHN05YpHPyqTXVw+G0UglRWhb6JDHgsB+FAHJ2
ujTzkbhgHsK6PT9BSIAuuBWzHbxRDCKBUtADI41jUKowKfRRQAUUUUAFFFFABRRRQAUUUUAFJRRQ
AUUUUADdKQdaKKAFooooAWiiigAooooAKKKKACiiigD/2Q==

------=_NextPart_01C9E539.2CB92EC0
Content-Location: file:///C:/C9064493/CalmanteseAnfetaminas_arquivos/filelist.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml; charset="utf-8"

<xml xmlns:o=3D"urn:schemas-microsoft-com:office:office">
 <o:MainFile HRef=3D"../CalmanteseAnfetaminas.htm"/>
 <o:File HRef=3D"themedata.thmx"/>
 <o:File HRef=3D"colorschememapping.xml"/>
 <o:File HRef=3D"image001.jpg"/>
 <o:File HRef=3D"image002.jpg"/>
 <o:File HRef=3D"filelist.xml"/>
</xml>
------=_NextPart_01C9E539.2CB92EC0--
